Genetic Technologies Ltd - GENE Net earnings per share for the last four quarters

Public company logo of GTG Labs (GENE)

Genetic Technologies serves as a global diagnostic partner, implementing genetic cancer risk screenings in clinics. The annual EPS (TTM) growth rate is currently trading in a sideways range, where the -53.10 metric determines the status of the parameter. Synergy with distributors via AI tests is advancing personalized medicine, while increasing sales of prostate and breast cancer diagnostics are reducing the impact of fixed costs.

GENE gtglabs.com: Net earnings per share (EPS TTM) in the range 02/11/2024 - 02/20/2024

GENE (Genetic Technologies Ltd): analytical breakdowns and indicator data

- market price and analyst price targets:
Fundamental company valuation:GENE, Genetic Technologies
Core merchandise of Genetic Technologies Limited

The efficiency of integrating GeneType tests into medical practice is directly reflected in profit dynamics. This annual growth in basic net income per share (ttm) measures the percentage change in EPS over the last twelve months relative to the previous year. Analysis of this chart reveals the pace of business scaling and the stability of cash flows. Sharp fluctuations in the indicator signal revenue volatility from preventive genomics. Stable growth confirms the fundamental value of Genetic Technologies (GENE) assets.

Direct competitors

A - Net earnings per share (EPS TTM)|Quest Corp (DGX) - Earnings per share for the last twelve months|ILMN - Net earnings per share for the last four quarters|Earnings per share for the last twelve months exactsciences.com|revvity.com (RVTY) - Net earnings per share for the last four quarters|Net earnings per share (EPS TTM) BIO|Net earnings per share (EPS TTM) Anbio Biotechnology Ltd (NNNN)|Sotera Health - Net earnings per share for the last 12 months|Net earnings per share (EPS TTM) QuidelOrtho Corp QDEL|OPK - Earnings per share for the last twelve months|Earnings per share for the trailing year CDNA (caredx.com)|MRVI: Net earnings per share (EPS TTM)|Net earnings per share for the trailing year Fulgent Genetics FLGT|LAB (Standard BioTools Inc) - Net earnings per share (EPS TTM)|Net earnings per share (EPS TTM) Cytek Biosciences, Inc.|Earnings per share for the last twelve months OraSure Technologies (OSUR)|XGN (Exagen) - Earnings per share for the trailing year|Earnings per share for the last twelve months MDxHealth MDXH|LUCD: Earnings per share for the last 12 months|PRE - Earnings per share for the last twelve months|Earnings per share for the trailing year IMDX (Insight Molecular Diagnostics Inc)|TRIB: Net earnings per share (EPS TTM)|prophaselabs.com - Earnings per share for the trailing year|Net earnings per share for the last 12 months AIMD|Co-Diagnostics Corp (CODX) - Net earnings per share for the last four quarters|Net earnings per share for the last 12 months HSCS (Heart Test Laboratories Inc.)|Net earnings per share for the last four quarters Biomerica Inc|Earnings per share for the last twelve months cardiodiagnosticsinc.com CDIO|ONCO: Earnings per share for the last 12 months|VRAX - Earnings per share for the last twelve months|BJDX (Bluejay Diagnostics Inc) - Earnings per share for the last 12 months|AWH: Net earnings per share (EPS TTM)|Accelerate Diagnostics, Inc (AXDX) - Net earnings per share (EPS TTM)|CNTG (CENTOGENE, N.V.) - Net earnings per share (EPS TTM)|Net earnings per share for the last 12 months Enzo Biochem (ENZ)|Net earnings per share for the last 12 months FRES (fresh2.co)|Net earnings per share for the last four quarters 23andMe Holding Co|Net earnings per share (EPS TTM) PMD (Psychemedics)